AU2014224252B2 - Process for the preparation of Deferasirox - Google Patents

Process for the preparation of Deferasirox

Info

Publication number
AU2014224252B2
AU2014224252B2 AU2014224252A AU2014224252A AU2014224252B2 AU 2014224252 B2 AU2014224252 B2 AU 2014224252B2 AU 2014224252 A AU2014224252 A AU 2014224252A AU 2014224252 A AU2014224252 A AU 2014224252A AU 2014224252 B2 AU2014224252 B2 AU 2014224252B2
Authority
AU
Australia
Prior art keywords
formula
deferasirox
hydroxyphenyl
oxazin
solvent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2014224252A
Other languages
English (en)
Other versions
AU2014224252A1 (en
Inventor
Reddy Gearu Damodar
Kothakonda Kiran KUMAR
Venkata Srinivas Pullela
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biocon Ltd
Original Assignee
Biocon Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocon Ltd filed Critical Biocon Ltd
Priority claimed from PCT/IB2014/059456 external-priority patent/WO2014136062A2/en
Publication of AU2014224252A1 publication Critical patent/AU2014224252A1/en
Application granted granted Critical
Publication of AU2014224252B2 publication Critical patent/AU2014224252B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/20—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 4
    • C07D265/22—Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AU2014224252A 2013-03-06 2014-03-05 Process for the preparation of Deferasirox Active AU2014224252B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN975/CHE/2013 2013-03-06
IN975CH2013 2013-03-06
PCT/IB2014/059456 WO2014136062A2 (en) 2013-03-06 2014-03-05 Process for the preparation of deferasirox

Publications (2)

Publication Number Publication Date
AU2014224252A1 AU2014224252A1 (en) 2015-09-24
AU2014224252B2 true AU2014224252B2 (en) 2016-09-22

Family

ID=54198664

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2014224252A Active AU2014224252B2 (en) 2013-03-06 2014-03-05 Process for the preparation of Deferasirox

Country Status (11)

Country Link
US (1) US9593086B2 (enExample)
EP (1) EP2964659B1 (enExample)
JP (1) JP6312718B2 (enExample)
KR (1) KR102282372B1 (enExample)
AU (1) AU2014224252B2 (enExample)
CA (1) CA2903712C (enExample)
DK (1) DK2964659T3 (enExample)
ES (1) ES2650118T3 (enExample)
NO (1) NO2964659T3 (enExample)
PL (1) PL2964659T3 (enExample)
RU (1) RU2659034C2 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11022880B2 (en) * 2017-10-25 2021-06-01 Tokyo Ohka Kogyo Co., Ltd. Chemically amplified positive-type photosensitive resin composition, photosensitive dry film, method of manufacturing photosensitive dry film, method of manufacturing patterned resist film, method of manufacturing substrate with template, method of manufacturing plated article, and mercapto compound

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6465504B1 (en) * 1996-06-25 2002-10-15 Novartis Ag Substituted 3,5-diphenyl-1,2,4-triazoles and their use as pharmaceutical metal chelators

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH478827A (de) * 1967-02-27 1969-09-30 Geigy Ag J R Verfahren zur Herstellung von Areno-oxazinonverbindungen
US20110097413A1 (en) * 2008-04-21 2011-04-28 Actavis Group Ptc Ehf Solid state forms of deferasirox salts and process for the preparation thereof
US20110171138A1 (en) * 2008-06-02 2011-07-14 Actavis Group Ptc Ehf Substantially pure deferasirox and processes for the preparation thereof
WO2010023685A2 (en) * 2008-08-29 2010-03-04 Matrix Laboratories Limited Crystalline form of 2-(2-hydroxy phenyl)benz[e][1,3]oxazin-4-one, process for the same and use for producing 4-(3,5-bis(2-hydroxyphenyl)-1h-1,2,4-triazol-1-yl)benzoic acid
WO2011021218A2 (en) * 2009-08-12 2011-02-24 Msn Laboratories Limited Process for the preparation of 4-[3,5-bis(2-hydroxyphenyl)-1h-1,2,4-triazol-1-yl]-benzoic acid and its amine salts
US8772503B2 (en) * 2009-12-07 2014-07-08 Mapi Pharma Ltd. Processes for the preparation of deferasirox, and deferasirox polymorphs
WO2012025935A2 (en) * 2010-08-25 2012-03-01 Ramamohan Rao Davuluri A process for the preparation of 2-(2-hydroxyphenyl)-benz[1,3]oxazin-4-one and its use for preparation of 4-[3, 5-bis (2-hydroxyphenyl)-1h-1, 2, 4-triazol-1-yl] benzoic acid
JP2012126882A (ja) * 2010-11-22 2012-07-05 Fujifilm Corp 紫外線吸収剤組成物
WO2012069946A1 (en) * 2010-11-24 2012-05-31 Alembic Pharmaceuticals Limited Process for the preparation of deferasirox
ITMI20110543A1 (it) * 2011-04-01 2012-10-02 Erregierre Spa Processo per la produzione di deferasirox

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6465504B1 (en) * 1996-06-25 2002-10-15 Novartis Ag Substituted 3,5-diphenyl-1,2,4-triazoles and their use as pharmaceutical metal chelators

Also Published As

Publication number Publication date
JP6312718B2 (ja) 2018-04-18
US20160024025A1 (en) 2016-01-28
US9593086B2 (en) 2017-03-14
EP2964659A4 (en) 2016-11-02
EP2964659B1 (en) 2017-08-09
JP2016515103A (ja) 2016-05-26
KR20150123934A (ko) 2015-11-04
KR102282372B1 (ko) 2021-07-27
RU2659034C2 (ru) 2018-06-27
AU2014224252A1 (en) 2015-09-24
ES2650118T3 (es) 2018-01-17
DK2964659T3 (da) 2017-11-27
CA2903712C (en) 2022-06-14
NO2964659T3 (enExample) 2018-01-06
EP2964659A2 (en) 2016-01-13
CA2903712A1 (en) 2014-09-12
PL2964659T3 (pl) 2018-04-30
RU2015139499A (ru) 2017-04-10

Similar Documents

Publication Publication Date Title
US6515128B2 (en) Processes for preparing cilostazol
JP3845059B2 (ja) シロスタゾールの製造方法
AU2014224252B2 (en) Process for the preparation of Deferasirox
EP2643306B1 (en) Process for the preparation of deferasirox
WO2014136062A2 (en) Process for the preparation of deferasirox
US20100029939A1 (en) Preparation of ketone amides
CA1082198A (en) Process for preparation of a therapeutically active compound
US8163924B2 (en) Process for preparing a leukotriene antagonist and an intermediate thereof
EP1038861B1 (en) 4-fluoro-3-oxocarboxylic esters and process for producing the same
FI77860B (fi) Foerfarande foer framstaellning av 5,11-dihydro-6h-pyrido /2,3-b/ /1,4/ benzodiazepin-6-oner.
JP4258590B2 (ja) ハロゲン置換キノリン誘導体の製造方法
CA2150948A1 (en) Process for the preparation of alpha-aryl-gamma-butyrolactones
US5703233A (en) Quinilone disulfide as intermediates
KR890002639B1 (ko) 퀴놀린 유도체의 제조 방법
KR860000671B1 (ko) 퀴놀린 카르복실산의 피페라지닐 유도체의 제조 방법
KR0119280B1 (ko) 신규한 5-메틸퀴놀론계 항생제의 중간체 및 이의 제조방법
KR900007627B1 (ko) 4-옥소퀴놀린 카복실산 유도체의 제조방법
JPH0234943B2 (enExample)
TW200538455A (en) Improved process for the preparation of (ethoxymethyl)-tropane derivatives
BG60588B1 (en) Method for the preparation of quinoline derivatives
KR19980047902A (ko) 퀴놀론계 항생제 중간체인 베타-케토 에스테르 유도체의 제조방법
JPH0233708B2 (enExample)

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)